# Wonderbelly

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wonderbelly

- Industry: Pharmaceuticals
- Headquarters: Austin, US
- Website: www.wonderbelly.com/
- Total disclosed funding: $15M
- Latest round: Series A (Apr 9, 2024)
- Investors on record: 8

## About

Based in Texas, US, and founded in 2021 by Noah Kraft (CEO) and Lucas, Health Company dba Wonderbelly develops and manufactures medicine for digestive health and heartburn conditions. In January 2026, Procter & Gamble Co. acquired Wonderbelly from The Venture Collective, AF Ventures, Silas Capital, Loft Growth Partners, L Catterton, Elizabeth Street Ventures, BrandProject, and Slow.

The company offers Wonderbelly antacids to fight against upset belly, heartburn, and indigestion. The firm has three variants of its product such as strawberry milkshake, citrus mint, and watermelon mint. The January 2026 acquisition enables Procter & Gamble Co. to add a modern, clean-label digestive-health brand to its portfolio to reach younger shoppers and expand product offerings.

## Funding rounds

- Series A, Apr 9, 2024, $11M — L Catterton, Loft Growth Partners, Silas Capital, BrandProject, AF Ventures, Elizabeth Street Ventures, The Venture Collective
- Seed, Jan 14, 2022, $3.2M — Slow, BrandProject, Elizabeth Street Ventures

## Investors

- Slow (https://capitalatlas.ai/funds/slow) — Seed
- BrandProject (https://capitalatlas.ai/funds/brandproject) — Seed, Series A
- Elizabeth Street Ventures (https://capitalatlas.ai/funds/elizabeth-street-ventures) — Seed, Series A
- L Catterton (https://capitalatlas.ai/funds/l-catterton) — Series A
- Loft Growth Partners (https://capitalatlas.ai/funds/loft-growth-partners) — Series A
- Silas Capital (https://capitalatlas.ai/funds/silas-capital) — Series A
- AF Ventures (https://capitalatlas.ai/funds/af-ventures) — Series A
- The Venture Collective (https://capitalatlas.ai/funds/the-venture-collective) — Series A